Abstract
AbstractSequential window acquisition of all theoretical fragment-ion spectra (SWATH) is a data-independent acquisition (DIA) strategy that requires a specific spectral library to generate unbiased and consistent quantitative data matrices of all peptides. SWATH-MS is a promising approach for in-depth proteomic profiling of Chinese hamster Ovary (CHO) cell lines, improving mechanistic understanding of process optimization, and real-time monitoring of process parameters in biologics R&D and manufacturing. However, no spectral library for CHO cells is publicly available. Here we present a comprehensive CHO global spectral library to measure the abundance of more than 10,000 proteins consisting of 199,102 identified peptides from a CHO-K1 cell proteome. The robustness, accuracy and consistency of the spectral library were validated for high confidence in protein identification and reproducible quantification in different CHO-derived cell lines, instrumental setups and downstream processing samples. The availability of a comprehensive SWATH CHO global spectral library will facilitate detailed characterization of upstream and downstream processes, as well as quality by design (QbD) in biomanufacturing. The data have been deposited to ProteomeXchange (PXD016047).
Publisher
Springer Science and Business Media LLC
Subject
Library and Information Sciences,Statistics, Probability and Uncertainty,Computer Science Applications,Education,Information Systems,Statistics and Probability
Reference45 articles.
1. Santos, R. et al. A comprehensive map of molecular drug targets. Nat. Rev. Drug Discov. 16, 19–34, https://doi.org/10.1038/nrd.2016.230 (2017).
2. Urquhart, L. Market watch: Top drugs and companies by sales in 2017. Nat. Rev. Drug Discov. 17, 232, https://doi.org/10.1038/nrd.2018.42 (2018).
3. Singh, S. et al. Monoclonal Antibodies: A Review. Curr Clin Pharmacol 13, 85–99, https://doi.org/10.2174/1574884712666170809124728 (2018).
4. Urquhart, L. Top drugs and companies by sales in 2018. Nat. Rev. Drug Discov., https://doi.org/10.1038/d41573-019-00049-0 (2019).
5. Howie, L. J., Hirsch, B. R. & Abernethy, A. P. A comparison of FDA and EMA drug approval: implications for drug development and cost of care. Oncology (Williston Park) 27, 1195, 1198–1200, 1202 passim (2013).
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献